A combination of α-fetoprotein, midkine, thioredoxin and a metabolite for predicting hepatocellular carcinoma.
CONCLUSION: This model may enhance early-stage HCC detection and help to overcome insufficient sensitivity of AFP.
PMID: 31648804 [PubMed - as supplied by publisher]
Source: Annals of Hepatology - Category: Gastroenterology Tags: Ann Hepatol Source Type: research
More News: Cancer & Oncology | Carcinoma | Cirrhosis | Gastroenterology | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | Liver | Liver Cancer | Study | Urology & Nephrology